InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,595.22
(
0.12%
)
US TECH 100
19,373.20
(
0.53%
)
Dow Jones
41,318.89
(
0.29%
)
Brent Oil
84.08
(
-0.49%
)
Bitcoin
64,225.44
(
0.22%
)
Post# of 1367
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: genisi post# 1077

Tuesday, 01/01/2013 8:45:55 AM

Tuesday, January 01, 2013 8:45:55 AM

Post# of 1367
Can-Fite (TASE:CFBI; OTC:CANFY)

CF101 Psoriasis Phase II/III quantitative interim results, see slide 12 in the presentation:

http://www.canfite.co.il/upload/2012-12-30_Can-Fite_Overview-English_isa.pdf

Not stat-sig vs placebo at 12 weeks with data from 103 patients, but with additional 188 patients I think it will be.
One odd observation: placebo switchers improved as soon as being put on the 2 mg drug (too quickly) after week 12.
The PR:

http://www.canfite.co.il/upload/2012-12-30%20Psoriasis%20additional%20analysis%20-%20English.pdf
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up